e.g. Tata motors, Reliance MF, 500570

Invesco India Pharma and Healthcare Fund - Direct Plan - IDCW

Equity Pharma Very High

NAV on (10 Sep 2026 )

₹10.02

(+0.20%)

Fund Size

₹0

1Y Returns

0.00 %

 
Earn 1% Higher Returns in Direct Funds on dhan Invest  Top Funds
Disclaimer: Mutual Fund investments are subject to market risks. Read all scheme related documents carefully before investing.

 

Investment Objective

To generate long term capital appreciation by investing predominantly in equity and equity related securities of the companies in Pharmaceuticals, Healthcare and allied sectors. There is no assurance that the investment objective of the Scheme will be achieved.

AMC

Invesco Asset Management (India) Private Limited

Fund Details

Launch Date

August 18, 2026

Fund Manager

Mr. Aditya Khemani

Initial Price

10

Min investment

Rs 1000

SIP Minimum Investment

Daily - Rs. 100/- and in multiples of Re. 1/- thereafter. Minimum 60 installments.Monthly - Rs. 100/- and in multiples of Re. 1/- thereafter. Minimum 12 installments.Monthly - Rs. 100/- and in multiples of Re. 1/- thereafter. Minimum 12 installments.Quarterly - Rs. 300/- and in multiples of Re. 1/- thereafter. Minimum 4 installments.

Exit Load

If units are redeemed/switched out on or before 3 months from the date of allotment: 0.50%If units are redeemed/switched-out after 3 months: NilSwitch between the Plans under the Scheme: Nil

1 Month

NA

6 Months

NA

1 Year

NA

2 Years (CAGR)

NA

3 Years (CAGR)

NA

5 Years (CAGR)

NA

Equity / Mid Cap funds 1Y 3Y Fund Size (Cr)
29.26% 0.00% ₹682.39
29.25% 0.00% ₹682.39
28.30% 0.00% ₹3310.64
28.30% 0.00% ₹3310.64
27.22% 0.00% ₹682.39
Address
Unit No: 2101 A,21st floor, A - Wing, Marathon Futurex, N. M. Joshi Marg, Lower Parel, Mumbai Maharashtra India 400013
Phone
+91 22 67310000
Fax
+91 22 23019422
Launch Date
August 18, 2026
Custodian
Deutsche Bank AG.
Registrar & Transfer Agent
KFIN Technologies Pvt. Ltd.

Frequently Asked Questions

Q: What is the current NAV of Invesco India Pharma and Healthcare Fund - Direct Plan - IDCW?

A: The latest NAV of Invesco India Pharma and Healthcare Fund - Direct Plan - IDCW is ₹ 10.02 as on 10 Sep 2026.

Q: What type of mutual fund is Invesco India Pharma and Healthcare Fund - Direct Plan - IDCW?

A: Invesco India Pharma and Healthcare Fund - Direct Plan - IDCW is a 'Equity - Pharma' type mutual fund managed by 'Invesco Asset Management (India) Private Limited'.

Q: Who manages Invesco India Pharma and Healthcare Fund - Direct Plan - IDCW?

A: Invesco India Pharma and Healthcare Fund - Direct Plan - IDCW is managed by Mr. Aditya Khemani, who oversees investment strategy and portfolio decisions.

Q: Is Invesco India Pharma and Healthcare Fund - Direct Plan - IDCW a good investment?

A: Invesco India Pharma and Healthcare Fund - Direct Plan - IDCW may be suitable depending on your financial goals, risk appetite, and investment horizon. Always evaluate fund performance and consult a financial advisor.

Q: What is the exit load of Invesco India Pharma and Healthcare Fund - Direct Plan - IDCW?

A: The exit load of Invesco India Pharma and Healthcare Fund - Direct Plan - IDCW is If units are redeemed/switched out on or before 3 months from the date of allotment: 0.50%If units are redeemed/switched-out after 3 months: NilSwitch between the Plans under the Scheme: Nil, applicable if redeemed within the specified period.

Q: How is Invesco India Pharma and Healthcare Fund - Direct Plan - IDCW taxed?

A: Taxation depends on the fund type (equity/debt) and holding period as per Indian tax laws.

Close

Add Invesco India Pharma and Healthcare Fund - Direct Plan to your Watchlist

Alert me if price...
Close

Add Invesco India Pharma and Healthcare Fund - Direct Plan to your Portfolio

:  
   
:    
 

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback